Form 8-K - Current report:
SEC Accession No. 0001104659-24-117704
Filing Date
2024-11-13
Accepted
2024-11-13 16:14:06
Documents
15
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428191d1_8k.htm   iXBRL 8-K 27273
2 EXHIBIT 99.1 tm2428191d1_ex99-1.htm EX-99.1 77503
6 GRAPHIC tm2428191d1_ex99-1img001.jpg GRAPHIC 9108
  Complete submission text file 0001104659-24-117704.txt   301306

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alms-20241113.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alms-20241113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alms-20241113_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428191d1_8k_htm.xml XML 3679
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42143 | Film No.: 241454379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)